NBC Securities’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$213K Sell
858
-20
-2% -$4.31K 0.01% 831
2026
Q1
$176K Sell
878
-52
-6% -$10.8K 0.01% 877
2025
Q4
$192K Buy
930
+17
+2% +$3.4K 0.01% 855
2025
Q3
$164K Sell
913
-217
-19% -$37K 0.01% 913
2025
Q2
$182K Sell
1,130
-236
-17% -$37.6K 0.01% 868
2025
Q1
$232K Buy
1,366
+1,364
+68,200% +$237K 0.02% 724
2024
Q4
$364 Sell
2
-2,269
-100% -$388K 0.03% 563
2024
Q3
$390K Sell
2,271
-103
-4% -$17.1K 0.03% 554
2024
Q2
$365K Buy
2,374
+168
+8% +$25.2K 0.03% 546
2024
Q1
$339K Sell
2,206
-103
-4% -$15.7K 0.03% 565
2023
Q4
$364K Sell
2,309
-115
-5% -$16.5K 0.04% 511
2023
Q3
$354K Buy
+2,424
New +$369K 0.04% 488

Other funds holding FBT

NBC Securities's FBT Position: Q2 2026 in Review

NBC Securities reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 2.3% in Q2 2026, selling an estimated $4.31K and leaving 858 shares worth $213K. The position accounts for 0.01% of the portfolio, ranked #831.

NBC Securities first reported a position in FBT in Q3 2023 and has held it in 12 quarters since. The position peaked at $390K in Q3 2024. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • NBC Securities held 858 shares of First Trust NYSE Arca Biotechnology Index Fund worth $213K as of Q2 2026.
  • NBC Securities sold 20 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $4.31K.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.01% of NBC Securities's portfolio in Q2 2026, its #831 holding.
  • NBC Securities first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2023 and has held it in 12 quarters since.
  • NBC Securities's First Trust NYSE Arca Biotechnology Index Fund position peaked at $390K in Q3 2024.
  • 339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.